Characterization of the interaction between subunits of the botulinum toxin complex produced by serotype D through tryptic susceptibility of the isolated components and complex forms
The 650 kDa large toxin complex (L-TC) produced by Clostridium botulinum serotype D strain 4947 (D-4947) has a subunit structure composed of unnicked components, i.e. neurotoxin (NT), non-toxic non-haemagglutinin (NTNHA) and three haemagglutinin subcomponents (HA-70, HA-33 and HA-17). In this study, subunit interactions were investigated through the susceptibilities of the toxin components to limited trypsin proteolysis. Additionally, complex forms were reconstituted in vitro by various combinations of individual components. Trypsin treatment of intact D-4947 L-TC led to the formation of mature L-TC with nicks at specific sites of each component, which is usually observed in other strains of serotype D. NT, NTNHA and HA-17 were cleaved at their specific sites in either the single or complex forms, but HA-33 showed no sign of proteolysis. Unlike the other components, HA-70 was digested into random fragments as a single form, but it was cleaved into two fragments in the complex form. Based on the relative position of exposed or hidden regions of the individual components in the complex derived from their tryptic susceptibilities, an assembly model is proposed for the arrangement of individual subunits in the botulinum L-TC.
ChenF.,
KuziemkoG. M.,
AmersdorferP.,
WongC.,
MarksJ. D.,
StevensR. C.
1997; Antibody mapping to domains of botulinum neurotoxin serotype A in the complexed and uncomplexed forms. Infect Immun 65:1626–1630
FuF. N.,
SharmaS. K.,
SinghB. R.
1998; A protease-resistant novel hemagglutinin purified from type A Clostridium botulinum
. J Protein Chem 17:53–60[CrossRef]
FujinagaY.,
InoueK.,
WatanabeS.,
YokotaK.,
HiraiY.,
NagamachiE.,
OgumaK.
1997; The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin. Microbiology 143:3841–3847[CrossRef]
FujinagaY.,
InoueK.,
NomuraT.,
SasakiJ.,
MarvaudJ. C.,
PopoffM. R.,
KozakiS.,
OgumaK.
2000; Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes. FEBS Lett 467:179–183[CrossRef]
FujinagaY.,
InoueK.,
WataraiS.10 other authors2004; Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes. Microbiology 150:1529–1538[CrossRef]
HasegawaK.,
WatanabeT.,
SatoH.10 other authors2004; Characterization of toxin complex produced by a unique strain of Clostridium botulinum serotype D 4947. Protein J 23:371–378[CrossRef]
HiranoH.,
WatanabeT.
1990; Microsequencing of proteins electrotransferred onto immobilizing matrices from polyacrylamide gel electrophoresis: application to an insoluble protein. Electrophoresis 11:573–580[CrossRef]
InoueK.,
SobhanyM.,
TransueT. R.,
OgumaK.,
PedersenL. C.,
NegishiM.
2003; Structural analysis by X-ray crystallography and calorimetry of a haemagglutinin component (HA1) of the progenitor toxin from Clostridium botulinum. Microbiology 149:3361–3370[CrossRef]
KouguchiH.,
WatanabeT.,
SaganeY.,
OhyamaT.
2001; Characterization and reconstitution of functional hemagglutinin of the Clostridium botulinum type C progenitor toxin. Eur J Biochem 268:4019–4026[CrossRef]
KouguchiH.,
WatanabeT.,
SaganeY.,
SunagawaH.,
OhyamaT.
2002; In vitro reconstitution of the Clostridium botulinum type D progenitor toxin. J Biol Chem 277:2650–2656[CrossRef]
KrieglsteinK. G.,
DasGuptaB. R.,
HenschenA. H.
1994; Covalent structure of botulinum neurotoxin type A: location of sulfhydryl groups, and disulfide bridges and identification of C-termini of light and heavy chains. J Protein Chem 13:49–57[CrossRef]
LacyD. B.,
TeppW.,
CohenA. C.,
DasGuptaB. R.,
StevensR. C.
1998; Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol 5:898–902[CrossRef]
ManavalanP.,
JohnsonW. C.
Jr 1987; Variable selection method improves the prediction of protein secondary structure from circular dichroism spectra. Anal Biochem 167:76–85[CrossRef]
MutohS.,
KouguchiH.,
SaganeY.,
SuzukiT.,
HasegawaK.,
WatanabeT.,
OhyamaT.
2003; Complete subunit structure of the Clostridium botulinum type D toxin complex via intermediate assembly with nontoxic components. Biochemistry 42:10991–10997[CrossRef]
SaganeY.,
WatanabeT.,
KouguchiH.,
SunagawaH.,
InoueK.,
FujinagaY.,
OgumaK.,
OhyamaT.
1999; Dichain structure of botulinum neurotoxin: identification of cleavage sites in types C, D, and F neurotoxin molecules. J Protein Chem 18:885–892[CrossRef]
SaganeY.,
WatanabeT.,
KouguchiH.,
SunagawaH.,
ObataS.,
OgumaK.,
OhyamaT.
2002; Spontaneous nicking in the nontoxic-nonhemagglutinin component of the Clostridium botulinum toxin complex. Biochem Biophys Res Commun 292:434–440[CrossRef]
SharmaS. K.,
FuF. N.,
SinghB. R.
1999; Molecular properties of a hemagglutinin purified from type A Clostridium botulinum
. J Protein Chem 18:29–38[CrossRef]
ShoneC. C.,
HambletonP.,
MellingJ.
1985; Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity. Eur J Biochem 151:75–82[CrossRef]
SimpsonL. L.
2000; Identification of the characteristics that underlie botulinum toxin potency: implications for designing novel drugs. Biochimie 82:943–953[CrossRef]
SwaminathanS.,
EswaramoorthyS.
2000; Crystallization and preliminary X-ray analysis of Clostridium botulinum neurotoxin type B. Acta Crystallogr D Biol Crystallogr 56:1024–1026[CrossRef]
WatanabeT.,
SaganeY.,
KouguchiH.,
SunagawaH.,
InoueK.,
FujinagaY.,
OgumaK.,
OhyamaT.
1999; Molecular composition of progenitor toxin produced by Clostridium botulinum type C strain 6813. J Protein Chem 18:753–760[CrossRef]
Characterization of the interaction between subunits of the botulinum toxin complex produced by serotype D through tryptic susceptibility of the isolated components and complex forms